ResMed Appoints New COO; Announces $20M Share Buyback

Effective September 1, 2011, ResMed

has appointed Robert Douglas, age 51, as a chief operating officer. Mr. Douglas will serve, together with the chairman and chief executive officer, Peter C. Farrell, PhD., in a newly-formed “office of the chief executive officer,” with full operational responsibility for ResMed and its subsidiaries. On August 24, 2011, the board of directors approved a new share repurchase program, authorizing the company to acquire up to an aggregate of 20 million shares of common stock.